Ultragenyx Pharmaceutical Inc.

0LIF.L·LSE
Compare
17.44+0.69 (+4.12%)today
As of Nov 4, 7:07 PM GMT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close16.75
Open15.48
Day range15.4817.63
52-week range12.8741.50
Off day high−1.08%
Off 52-week high−57.98%
Volume0.00
Avg. volume (3M)19.99K
Market cap—
EPS (TTM)-6.87
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.36
Shares outstanding50.58M
Short interest—
Earnings dateNov 3, 2026
Analyst target—
Profit margin−81.73%

Against its peers

Compare in full ›
0LIF.L BIIB XRTX MREO BBIO ROIV
Market cap — 37.62B 1.80M 47.76M 15.17B 27.11B
P/E (TTM) — 110.2 — — — —
Forward P/E — 15.7 1.2 -12.9 -225.0 -27.0
Price/book -21.0 2.0 0.3 1.7 -5.9 6.4
Dividend yield — — — — — —
1-year change −44.91% +62.35% −65.92% −82.78% +24.17% +85.85%
Today +4.12% +0.02% −1.00% −1.30% +5.21% −1.83%

The closest companies by business. Prices may be delayed up to 15 min.

Latest news

All 0LIF.L news ›

From the 4Search news index, newest first.

In the news

24mentions in 30 days
24with it in the headline
Negativesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance